Testing for Neuroendocrine Immunohistochemical Markers Should Not Be Performed in Poorly Differentiated NSCCs in the Absence of Neuroendocrine Morphologic Features according to the 2015 WHO Classification

J Thorac Oncol. 2016 Feb;11(2):e26-7. doi: 10.1016/j.jtho.2015.10.018.

¹ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: travisw@mskcc.org.
² Department d'Anatomie et Cytologie Pathologiques, CHU Albert Michallon, University Joseph Fourier, INSERM U823 Institut Albert Bonniot, Grenoble, France.
³ Department of Pathology, Royal Brompton Hospital, London, United Kingdom.

No abstract available

Publication types